Safe and cost-effective control of post-transplantation recurrence of hepatitis B

A combination of hepatitis B immunoglobulin (HBIG) and nucleoside/nucleotide analogs (NUC) is the current standard of care for controlling hepatitis B recurrence after orthotopic liver transplantation (OLT). However, long-term HBIG administration is associated with several unresolved issues, includi...

Descripción completa

Detalles Bibliográficos
Autores principales: Takaki, Akinobu, Yagi, Takahito, Yamamoto, Kazuhide
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BlackWell Publishing Ltd 2015
Materias:
Review Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4309460/
https://www.ncbi.nlm.nih.gov/pubmed/24905970
http://dx.doi.org/10.1111/hepr.12368

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4309460/
https://www.ncbi.nlm.nih.gov/pubmed/24905970
http://dx.doi.org/10.1111/hepr.12368

Ejemplares similares